{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:58:50Z","timestamp":1726919930098},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00059-019-4802-y","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T14:55:04Z","timestamp":1554216904000},"page":"315-323","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management von intrazerebralen Blutungen unter oraler Antikoagulation"],"prefix":"10.1007","volume":"44","author":[{"given":"J. A.","family":"Sembill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Kuramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. B.","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"issue":"7","key":"4802_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/str.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS et\u00a0al (2015) Heart 46(7):2032\u20132060. \n                    https:\/\/doi.org\/10.1161\/str.0000000000000069","journal-title":"Heart"},{"issue":"1","key":"4802_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/STROKEAHA.113.003003","volume":"45","author":"AM Schols","year":"2014","unstructured":"Schols AM, Schreuder FH, van Raak EP et al (2014) Incidence of oral anticoagulant-associated intracerebral hemorrhage in the Netherlands. Stroke 45(1):268\u2013270. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.113.003003","journal-title":"Stroke"},{"issue":"8","key":"4802_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jama.2015.0846","volume":"313","author":"JB Kuramatsu","year":"2015","unstructured":"Kuramatsu JB et al (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313(8):824\u2013836. \n                    https:\/\/doi.org\/10.1001\/jama.2015.0846","journal-title":"JAMA"},{"issue":"2","key":"4802_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s1474-4422(09)70340-0","volume":"9","author":"CJ Asch van","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ et al (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a\u00a0systematic review and meta-analysis. Lancet Neurol 9(2):167\u2013176. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(09)70340-0","journal-title":"Lancet Neurol"},{"issue":"2","key":"4802_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1161\/STROKEAHA.108.523209","volume":"40","author":"S Sacco","year":"2009","unstructured":"Sacco S, Marini C, Toni D et al (2009) Incidence and 10-year survival of intracerebral hemorrhage in a\u00a0population-based registry. Stroke 40(2):394\u2013399. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.108.523209","journal-title":"Stroke"},{"issue":"9675","key":"4802_CR6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/s0140-6736(09)60371-8","volume":"373","author":"AI Qureshi","year":"2009","unstructured":"Qureshi AI, Mendelow AD, Hanley DF (2009) Intracerebral haemorrhage. Lancet 373(9675):1632\u20131644. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(09)60371-8","journal-title":"Lancet"},{"issue":"4","key":"4802_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.194","volume":"13","author":"L Fabritz","year":"2016","unstructured":"Fabritz L, Guasch E, Antoniades C et\u00a0al (2016) Expert consensus document: defining the major health modifiers causing atrial fibrillation: a\u00a0roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol 13(4):230\u2013237. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2015.194","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"4802_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","volume":"26","author":"RG Hart","year":"1995","unstructured":"Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26(8):1471\u20131477","journal-title":"Stroke"},{"issue":"20","key":"4802_CR9","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1212\/WNL.0b013e3182377e12","volume":"77","author":"A Biffi","year":"2011","unstructured":"Biffi A et al (2011) Warfarin-related intraventricular hemorrhage: imaging and outcome. Baillieres Clin Neurol 77(20):1840\u20131846. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182377e12","journal-title":"Baillieres Clin Neurol"},{"issue":"6","key":"4802_CR10","first-page":"1059","volume":"63","author":"JJ Flibotte","year":"2004","unstructured":"Flibotte JJ et\u00a0al (2004) Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Baillieres Clin Neurol 63(6):1059\u20131064","journal-title":"Baillieres Clin Neurol"},{"issue":"4","key":"4802_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2016-315346","volume":"88","author":"G Boulouis","year":"2017","unstructured":"Boulouis G et al (2017) Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J\u00a0Neurol Neurosurg Psychiatry 88(4):339\u2013345. \n                    https:\/\/doi.org\/10.1136\/jnnp-2016-315346","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4802_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamaneurol.2013.5433","volume":"71","author":"HB Brouwers","year":"2014","unstructured":"Brouwers HB, Chang Y, Falcone GJ et\u00a0al (2014) Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 71(2):158\u2013164. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.5433","journal-title":"JAMA Neurol"},{"key":"4802_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy056","author":"JB Kuramatsu","year":"2018","unstructured":"Kuramatsu JB, Sembill JA, Gerner ST et\u00a0al (2018) Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart\u00a0J. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehy056","journal-title":"Eur Heart J"},{"issue":"6","key":"4802_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","volume":"15","author":"T Steiner","year":"2016","unstructured":"Steiner T, Poli S, Griebe M et\u00a0al (2016) Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a\u00a0randomised trial. Lancet Neurol 15(6):566\u2013573. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(16)00110-1","journal-title":"Lancet Neurol"},{"issue":"12","key":"4802_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/jamaneurol.2013.4021","volume":"70","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ (2013) New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol 70(12):1486\u20131490. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.4021","journal-title":"JAMA Neurol"},{"issue":"5","key":"4802_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.2017.21917","volume":"319","author":"T Inohara","year":"2018","unstructured":"Inohara T et al (2018) Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality. JAMA 319(5):463\u2013473. \n                    https:\/\/doi.org\/10.1001\/jama.2017.21917","journal-title":"JAMA"},{"issue":"1","key":"4802_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.25134","volume":"83","author":"ST Gerner","year":"2018","unstructured":"Gerner ST et al (2018) Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Ann Neurol 83(1):186\u2013196. \n                    https:\/\/doi.org\/10.1002\/ana.25134","journal-title":"Ann Neurol"},{"issue":"7","key":"4802_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1538-7836.2010.03882.x","volume":"8","author":"GW Hawryluk","year":"2010","unstructured":"Hawryluk GW, Austin JW, Furlan JC et\u00a0al (2010) Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J\u00a0Thromb Haemostasis 8(7):1500\u20131508. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03882.x","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"4802_CR19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/WNL.0000000000004362","volume":"89","author":"G Tsivgoulis","year":"2017","unstructured":"Tsivgoulis G, Lioutas VA, Varelas P et al (2017) Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Baillieres Clin Neurol 89(11):1142\u20131151. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004362","journal-title":"Baillieres Clin Neurol"},{"issue":"13","key":"4802_CR20","doi-asserted-by":"publisher","first-page":"e1143","DOI":"10.1212\/WNL.0000000000005207","volume":"90","author":"R Kurogi","year":"2018","unstructured":"Kurogi R, Nishimura K, Nakai M et\u00a0al (2018) Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin. Baillieres Clin Neurol 90(13):e1143\u2013e1149. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000005207","journal-title":"Baillieres Clin Neurol"},{"issue":"1","key":"4802_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13054-017-1619-z","volume":"21","author":"M Ebner","year":"2017","unstructured":"Ebner M, Birschmann I, Peter A et al (2017) Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants. Crit Care 21(1):32. \n                    https:\/\/doi.org\/10.1186\/s13054-017-1619-z","journal-title":"Crit Care"},{"issue":"5","key":"4802_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack Jr.","year":"2017","unstructured":"Pollack CV Jr., Reilly PA, van Ryn J et\u00a0al (2017) Idarucizumab for dabigatran reversal \u2013 full cohort analysis. N\u00a0Engl J Med 377(5):431\u2013441. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707278","journal-title":"N Engl J Med"},{"issue":"12","key":"4802_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et\u00a0al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N\u00a0Engl J Med 361(12):1139\u20131151. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0905561","journal-title":"N Engl J Med"},{"issue":"10","key":"4802_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11910-018-0872-0","volume":"18","author":"JA Sembill","year":"2018","unstructured":"Sembill JA et al (2018) Impact of recent studies for the treatment of Intracerebral hemorrhage. Curr Neurol Neurosci Rep 18(10):71. \n                    https:\/\/doi.org\/10.1007\/s11910-018-0872-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4802_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607887","author":"SJ Connolly","year":"2016","unstructured":"Connolly SJ, Milling TJ Jr., Eikelboom JW et\u00a0al (2016) Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N\u00a0Engl J Med. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1607887","journal-title":"N Engl J Med"},{"issue":"25","key":"4802_CR26","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","volume":"373","author":"DM Siegal","year":"2015","unstructured":"Siegal DM, Curnutte JT, Connolly SJ et\u00a0al (2015) Andexanet alfa for the reversal of factor Xa inhibitor activity. N\u00a0Engl J Med 373(25):2413\u20132424. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1510991","journal-title":"N Engl J Med"},{"issue":"2","key":"4802_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GY Lip","year":"2011","unstructured":"Lip GY, Frison L, Halperin JL, Lane DA (2011) Comparative validation of a\u00a0novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J\u00a0Am Coll Cardiol 57(2):173\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2010.09.024","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"4802_CR28","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF, van Walraven C, Pearce L et\u00a0al (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110(16):2287\u20132292. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000145172.55640.93","journal-title":"Circulation"},{"issue":"9","key":"4802_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/jama.2015.10082","volume":"314","author":"A Biffi","year":"2015","unstructured":"Biffi A et\u00a0al (2015) Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA 314(9):904\u2013912. \n                    https:\/\/doi.org\/10.1001\/jama.2015.10082","journal-title":"JAMA"},{"issue":"7","key":"4802_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","volume":"9","author":"T Steiner","year":"2014","unstructured":"Steiner T, Al-Shahi Salman R, Beer R et al (2014) European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 9(7):840\u2013855. \n                    https:\/\/doi.org\/10.1111\/ijs.12309","journal-title":"Int J Stroke"},{"issue":"12","key":"4802_CR31","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","volume":"41","author":"A Majeed","year":"2010","unstructured":"Majeed A, Kim YK, Roberts RS et\u00a0al (2010) Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 41(12):2860\u20132866. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.110.593087","journal-title":"Stroke"},{"issue":"1","key":"4802_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cjca.2011.10.002","volume":"28","author":"D Yung","year":"2012","unstructured":"Yung D et al (2012) Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol 28(1):33\u201339. https:\/\/doi.org\/10.1016\/j.cjca\u00a0.2011.10.002 S0828-282X(11)01310-9","journal-title":"Can J Cardiol"},{"issue":"12","key":"4802_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1212\/WNL.0000000000000245","volume":"82","author":"D Poli","year":"2014","unstructured":"Poli D, Antonucci E, Dentali F et\u00a0al (2014) Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Baillieres Clin Neurol 82(12):1020\u20131026. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000245","journal-title":"Baillieres Clin Neurol"},{"issue":"6","key":"4802_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","volume":"132","author":"PB Nielsen","year":"2015","unstructured":"Nielsen PB, Larsen TB, Skjoth F et\u00a0al (2015) Restarting anticoagulant treatment after Intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study. Circulation 132(6):517\u2013525. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015735","journal-title":"Circulation"},{"issue":"7","key":"4802_CR35","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/STROKEAHA.116.012945","volume":"47","author":"TP Ottosen","year":"2016","unstructured":"Ottosen TP, Grijota M, Hansen ML et al (2016) Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage. Stroke 47(7):1837\u20131843. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.012945","journal-title":"Stroke"},{"issue":"9","key":"4802_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.hrthm.2016.05.016","volume":"13","author":"YA Park","year":"2016","unstructured":"Park YA, Uhm JS, Pak HN et\u00a0al (2016) Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage. Heart Rhythm 13(9):1794\u20131802. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2016.05.016","journal-title":"Heart Rhythm"},{"issue":"4","key":"4802_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/STROKEAHA.115.012338","volume":"47","author":"AS Vestergaard","year":"2016","unstructured":"Vestergaard AS, Skjoth F, Lip GY, Larsen TB (2016) Effect of anticoagulation on hospitalization costs after intracranial hemorrhage in atrial fibrillation: a registry study. Stroke 47(4):979\u2013985. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.115.012338","journal-title":"Stroke"},{"issue":"2","key":"4802_CR38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","volume":"48","author":"J Pennlert","year":"2017","unstructured":"Pennlert J, Overholser R, Asplund K et\u00a0al (2017) Optimal timing of anticoagulant treatment after Intracerebral hemorrhage in patients with atrial fibrillation. Stroke 48(2):314\u2013320. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.014643","journal-title":"Stroke"},{"issue":"16","key":"4802_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.115.019794","volume":"133","author":"TF Chao","year":"2016","unstructured":"Chao TF, Liu CJ, Liao JN et\u00a0al (2016) Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a\u00a0history of Intracranial hemorrhage. Circulation 133(16):1540\u20131547. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019794","journal-title":"Circulation"},{"issue":"7","key":"4802_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/WNL.0000000000004235","volume":"89","author":"E Korompoki","year":"2017","unstructured":"Korompoki E, Filippidis FT, Nielsen PB et al (2017) Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. Neurology 89(7):687\u2013696. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004235","journal-title":"Neurology"},{"issue":"6","key":"4802_CR41","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","volume":"48","author":"SB Murthy","year":"2017","unstructured":"Murthy SB, Gupta A, Merkler AE et al (2017) Restarting anticoagulant therapy after Intracranial hemorrhage: a systematic review and meta-analysis. Stroke 48(6):1594\u20131600. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.016327","journal-title":"Stroke"},{"key":"4802_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2017.11.001","volume":"160","author":"C Chai-Adisaksopha","year":"2017","unstructured":"Chai-Adisaksopha C et al (2017) Warfarin resumption following anticoagulant-associated intracranial hemorrhage: a systematic review and meta-analysis. Thromb Res 160:97\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.thromres.2017.11.001","journal-title":"Thromb Res"},{"issue":"5","key":"4802_CR43","doi-asserted-by":"publisher","first-page":"e019672","DOI":"10.1136\/bmjopen-2017-019672","volume":"8","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Yu J, Carcel C et al (2018) Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis. BMJ Open 8(5):e19672. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2017-019672","journal-title":"BMJ Open"},{"issue":"5","key":"4802_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.25079","volume":"82","author":"A Biffi","year":"2017","unstructured":"Biffi A, Kuramatsu JB, Leasure A et\u00a0al (2017) Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann Neurol 82(5):755\u2013765. \n                    https:\/\/doi.org\/10.1002\/ana.25079","journal-title":"Ann Neurol"},{"issue":"10","key":"4802_CR45","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1007\/s00415-018-9009-2","volume":"265","author":"JA Sembill","year":"2018","unstructured":"Sembill JA, Wieser CY, Sprugel MI et\u00a0al (2018) Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations. J\u00a0Neurol 265(10):2404\u20132414. \n                    https:\/\/doi.org\/10.1007\/s00415-018-9009-2","journal-title":"J Neurol"},{"issue":"5","key":"4802_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0000000000004174","volume":"89","author":"JA Sembill","year":"2017","unstructured":"Sembill JA et al (2017) Severity assessment in maximally treated ICH patients: the max-ICH score. Baillieres Clin Neurol 89(5):423\u2013431. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004174","journal-title":"Baillieres Clin Neurol"},{"issue":"10","key":"4802_CR47","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ene.13742","volume":"25","author":"AH Katsanos","year":"2018","unstructured":"Katsanos AH, Schellinger PD, Kohrmann M et al (2018) Fatal oral anticoagulant-related intracranial hemorrhage: a\u00a0systematic review and meta-analysis. Eur J Neurol 25(10):1299\u20131302. \n                    https:\/\/doi.org\/10.1111\/ene.13742","journal-title":"Eur J Neurol"},{"issue":"7","key":"4802_CR48","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/jth.14131","volume":"16","author":"Z Wolfe","year":"2018","unstructured":"Wolfe Z et al (2018) A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants. J\u00a0Thromb Haemost 16(7):1296\u20131306. \n                    https:\/\/doi.org\/10.1111\/jth.14131","journal-title":"J Thromb Haemost"},{"issue":"21","key":"4802_CR49","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/circulationaha.110.004747","volume":"123","author":"JW Eikelboom","year":"2011","unstructured":"Eikelboom JW, Wallentin L, Connolly SJ et al (2011) Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 123(21):2363\u20132372. \n                    https:\/\/doi.org\/10.1161\/circulationaha.110.004747","journal-title":"Circulation"},{"issue":"10","key":"4802_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.acvd.2012.09.001S1875-2136(12)00243-4","volume":"105","author":"A Vahanian","year":"2012","unstructured":"Vahanian A, Iung B (2012) The new ESC\/EACTS guidelines on the management of valvular heart disease. Arch Cardiovasc Dis 105(10):465\u2013467. \n                    https:\/\/doi.org\/10.1016\/j.acvd.2012.09.001S1875-2136(12)00243-4","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"4802_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA et\u00a0al (2017) 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J\u00a0Am Coll Cardiol 70(2):252\u2013289. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.03.011","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"4802_CR52","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/eurheartj\/ehw454","volume":"38","author":"S Halvorsen","year":"2017","unstructured":"Halvorsen S, Storey RF, Rocca B et\u00a0al (2017) Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart\u00a0J 38(19):1455\u20131462. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw454","journal-title":"Eur Heart J"},{"issue":"3","key":"4802_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","volume":"17","author":"MA Rodrigues","year":"2018","unstructured":"Rodrigues MA, Samarasekera N, Lerpiniere C et\u00a0al (2018) The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol 17(3):232\u2013240. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(18)30006-1","journal-title":"Lancet Neurol"},{"issue":"17","key":"4802_CR54","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad60574\/17\/1346","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P et\u00a0al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74(17):1346\u20131350. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181dad60574\/17\/1346","journal-title":"Neurology"},{"issue":"14","key":"4802_CR55","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1212\/WNL.0000000000003181","volume":"87","author":"ES Etten van","year":"2016","unstructured":"van Etten ES, Gurol ME, van der Grond J et\u00a0al (2016) Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy. Neurology 87(14):1482\u20131487. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003181","journal-title":"Neurology"},{"issue":"8","key":"4802_CR56","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Imaizumi T, Moulin S et al (2017) Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology 89(8):820\u2013829. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004259","journal-title":"Neurology"},{"issue":"23","key":"4802_CR57","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A et al (2017) Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF. Neurology 89(23):2317\u20132326. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004704","journal-title":"Neurology"},{"issue":"18","key":"4802_CR58","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/wnl.0000000000003281","volume":"87","author":"D Roongpiboonsopit","year":"2016","unstructured":"Roongpiboonsopit D et\u00a0al (2016) Cortical superficial siderosis predicts early recurrent lobar hemorrhage. Neurology 87(18):1863\u20131870. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000003281","journal-title":"Neurology"},{"issue":"9689","key":"4802_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a\u00a0randomised non-inferiority trial. Lancet 374(9689):534\u2013542. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61343-X","journal-title":"Lancet"},{"issue":"1","key":"4802_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr.","year":"2014","unstructured":"Holmes DR Jr., Kar S, Price MJ et al (2014) Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J\u00a0Am Coll Cardiol 64(1):1\u201312. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"4802_CR61","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","volume":"65","author":"DR Holmes Jr","year":"2015","unstructured":"Holmes DR Jr S et al (2015) Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J\u00a0Am Coll Cardiol 65(24):2614\u20132623","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"4802_CR62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/eurheartj\/ehw330","volume":"38","author":"JP Piccini","year":"2017","unstructured":"Piccini JP, Sievert H, Patel MR (2017) Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. Eur Heart\u00a0J 38(12):869\u2013876. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw330","journal-title":"Eur Heart J"},{"issue":"25","key":"4802_CR63","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035S0735-1097(13)01415-0","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, Mobius-Winkler S, Miller MA et al (2013) Left atrial appendage closure with the Watchman device in patients with a\u00a0contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J\u00a0Am Coll Cardiol 61(25):2551\u20132556. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.03.035S0735-1097(13)01415-0","journal-title":"J Am Coll Cardiol"},{"key":"4802_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et\u00a0al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart\u00a0J. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"issue":"3","key":"4802_CR65","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","volume":"13","author":"JE Nielsen-Kudsk","year":"2017","unstructured":"Nielsen-Kudsk JE et al (2017) Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a\u00a0propensity score-matched follow-up study. EuroIntervention 13(3):371\u2013378. \n                    https:\/\/doi.org\/10.4244\/EIJ-D-17-00201","journal-title":"EuroIntervention"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-019-4802-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:03:06Z","timestamp":1585699386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-019-4802-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4802"],"URL":"https:\/\/doi.org\/10.1007\/s00059-019-4802-y","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"2 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.A.\u00a0Sembill, J.B.\u00a0Kuramatsu, S.H.\u00a0Hohnloser und H.B.\u00a0Huttner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}